1. Dubinett SM, Kradin RL: Cytokine immunotherapy of non-small cell lung cancer. Reg Immunol 1993, 5:232–243. This review is an excellent summary of the potential importance of cytokines in non-small-cell lung cancer. The importance of local paracrine effects of cytokines is emphasized.
2. Atkins MB, Gould JA, Allegretta M, et al.: Phase I evaluation of recombinant interleukin 2 in patients with advanced malignant disease. J Clin Oncol 1986, 4:1380–1391.
3. Lee RE, Lotze MT, Skibber JM, et al.: Cardiorespiratory effects of immunotherapy with interleukin-2. J Clin Oncol 1989, 7:7–20.
4. Morita T, Ikeda K, Douzono M, et al.: Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 1996, 88:955–961.
5. Ohira T, Ohe Y, Heike Y, et al.: Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline. Gene Ther 1994, 1:269–275.